TIGIT and COVID-19: Upregulation of co-inhibitory receptors, including cytotoxic T-lymphocyte–associated protein 4, programmed cell death protein 1, lymphocyte-activation gene 3, and T-cell immunoglobulin mucin-3, including TIGIT, has been reported in COVID-19 patients in other studies (5).